Huaren Pharmaceutical Co Ltd (300110) — Net Asset Quality Index
Huaren Pharmaceutical Co Ltd (300110) has a Net Asset Quality Index of 33.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.79 Billion minus total liabilities of CN¥1.86 Billion yields net assets of CN¥925.86 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check 300110 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Huaren Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2007–2025)
This chart shows how Huaren Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the index stands at 33.2%, representing net assets of CN¥925.86 Million against total assets of CN¥2.79 Billion CNY. See Huaren Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Huaren Pharmaceutical Co Ltd (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Huaren Pharmaceutical Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300110 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 33.6% | CN¥909.06 Million | CN¥2.70 Billion | CN¥1.79 Billion | ▼ -6.4 pp |
| 2024 | 40.1% | CN¥1.37 Billion | CN¥3.43 Billion | CN¥2.05 Billion | ▼ -13.5 pp |
| 2023 | 53.5% | CN¥2.77 Billion | CN¥5.17 Billion | CN¥2.40 Billion | ▲ +3.2 pp |
| 2022 | 50.4% | CN¥2.60 Billion | CN¥5.16 Billion | CN¥2.56 Billion | ▲ +7.0 pp |
| 2021 | 43.3% | CN¥2.44 Billion | CN¥5.64 Billion | CN¥3.20 Billion | ▼ -24.9 pp |
| 2020 | 68.2% | CN¥2.33 Billion | CN¥3.42 Billion | CN¥1.09 Billion | ▼ -14.8 pp |
| 2019 | 83.0% | CN¥2.25 Billion | CN¥2.71 Billion | CN¥461.81 Million | ▲ +11.4 pp |
| 2018 | 71.5% | CN¥2.25 Billion | CN¥3.15 Billion | CN¥897.11 Million | ▲ +17.9 pp |
| 2017 | 53.6% | CN¥1.55 Billion | CN¥2.89 Billion | CN¥1.34 Billion | ▼ -2.4 pp |
| 2016 | 56.0% | CN¥1.53 Billion | CN¥2.72 Billion | CN¥1.20 Billion | ▲ +3.6 pp |
| 2015 | 52.4% | CN¥1.44 Billion | CN¥2.75 Billion | CN¥1.31 Billion | ▼ -4.1 pp |
| 2014 | 56.4% | CN¥1.48 Billion | CN¥2.62 Billion | CN¥1.14 Billion | ▼ -5.2 pp |
| 2013 | 61.7% | CN¥1.46 Billion | CN¥2.37 Billion | CN¥907.56 Million | ▼ -13.4 pp |
| 2012 | 75.0% | CN¥1.34 Billion | CN¥1.78 Billion | CN¥445.69 Million | ▼ -20.5 pp |
| 2011 | 95.5% | CN¥1.19 Billion | CN¥1.25 Billion | CN¥55.77 Million | ▼ -0.3 pp |
| 2010 | 95.9% | CN¥1.10 Billion | CN¥1.15 Billion | CN¥47.60 Million | ▲ +46.5 pp |
| 2009 | 49.4% | CN¥313.80 Million | CN¥635.78 Million | CN¥321.98 Million | ▲ +5.8 pp |
| 2008 | 43.6% | CN¥221.03 Million | CN¥507.33 Million | CN¥286.30 Million | ▼ -7.4 pp |
| 2007 | 51.0% | CN¥184.68 Million | CN¥362.18 Million | CN¥177.50 Million | — |